PODCAST: Understanding the Rapidly Evolving Science and Best Practices in Multiple Myeloma


December 23rd, 2020 - December 23rd, 2021

Faculty & Disclosures

Beth FaimanBeth Faiman, PhD, RN, MSN, APRN-BC, AOCN, FAAN
Nurse Practitioner and Nurse Scientist 
Cleveland Clinic 
Department of Hematology and Medical Oncology 
Cleveland, OH 

Faculty Bio

Beth Faiman PhD, MSN, APRN-BC, AOCN received a bachelor of science in nursing and registered nurse certification at Ursuline College in Pepper Pike, Ohio, completed in 1996. She received a master of science in nursing and certification as an adult nurse practitioner at Kent State University in Kent, Ohio in 2002 and a PhD in Clinical Research and Nursing from Case Western Reserve University in 2014.

Dr. Faiman holds an advanced oncology nurse certification through ONCC. She is currently employed as an Adult Nurse Practitioner in the department of Hematologic Oncology and Blood Disorders at the Cleveland Clinic in Cleveland, Ohio. She is adjunct faculty at Ursuline College, Case Western Reserve University and Kent State University. She received the 2012 Excellence in Medical Oncology and 2013 Commendation for Patient and Nursing Education Award sponsored by The Oncology Nursing Society and the 2015 Dean’s Legacy Award for PhD Studies from Case Western Reserve University and was named the Leukemia and Lymphoma Society’s Woman of the Year for Cleveland and Akron Ohio, 2016.

Dr. Faiman is an active author, presenter, and educator on the topic of multiple myeloma, chronic lymphocytic leukemia, plasma cell dyscrasias, general cancer diagnosis and treatment, as well as management of skeletal and other cancer complications. She is an appointed delegate on the International Myeloma Foundation Nurse Leadership Board. She is currently Editor-in-Chief of the Oncology Nurse APN/PA and on the editorial board of ASH Clinical News among others. She has edited several books, authored many chapters, and written numerous articles relating to the diagnosis and treatment of multiple myeloma, treatment adherence, pain, palliation, and cancer symptom management.

Faculty Disclosure Statement
Beth Faiman has served as a consultant for Bristol Myers Squibb, Sanofi, and GSK.

Planning Committee & Non-faculty Contributors 
Non-faculty contributors and others involved in the planning, development, and editing/review of the content disclose no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 12 months. 

Learner Assurance Statement
Horizon CME requires instructors, planners, managers and other individuals who are in a position to influence the content of this activity to disclose any real or apparent conflict of interest (COI) which may arise as a result of prospective faculty members' relevant relationships with drug or device manufacturer(s). Horizon CME is committed to resolving all conflicts of interest and retaining only those speakers with financial interest conflicts that can be reconciled with the goals and educational integrity of the CME activity.